International Patent: COMBINATION COMPRISING A TUMOR NECROSIS FACTOR RECEPTOR 2 AGONIST

GENEVA, June 26 -- RESANO GMBH filed a patent application (EP2025/085198) for “COMBINATION COMPRISING A TUMOR NECROSIS FACTOR RECEPTOR 2 AGONIST”. With publication no. WO/2026/119935, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/24

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....